Cannabis gene variants linked to CBG-dominant profiles mapped

Complementation of independent mutations resulting in CBG-dominant Cannabis sativa L.

Plant physiology β€’ β€’ Highly Relevant
πŸ€–

AI Summary

This study asked how different genetic changes in Cannabis sativa can lead to a CBG-dominant cannabinoid profile. The researchers characterized genomic regions around four independently identified mutations, including one that deletes the gene for cannabidiolic acid synthase. They compared these regions with more than 150 publicly available genome assemblies and identified 39 structurally distinct haplogroupsβ€”groups of related genetic variants in this variable region.

The team also developed molecular markers to detect the mutated haplogroups and created more than 30 populations combining them with one another or with functional haplogroups, then characterized their cannabinoid profiles. The abstract says these comparisons provide insight into genetic variation associated with cannabinoid profiles, but does not report specific profile outcomes. This is a plant-genetics study, not a human or animal treatment study; based on the abstract alone, it cannot establish how useful the markers or genetic combinations will be in practice.

πŸ’‘ Key Findings

1
The researchers identified 39 structurally distinct haplogroups in a variable genomic region involved in cannabinoid production.
High
90%
2
They developed molecular markers to assay for four mutated haplogroups associated with CBG-dominant profiles.
High
85%
3
More than 30 plant populations were generated and characterized to examine cannabinoid-profile variation associated with combinations of mutated and functional haplogroups; the abstract does not provide specific profile results.
High
80%

πŸ“„ Original Abstract

Cannabinoid biosynthesis in Cannabis sativa is governed by a specialized metabolic pathway that culminates in the production of a diverse set of bioactive compounds. The first committed step in this pathway is the synthesis of cannabigerolic acid, which serves as a common precursor to other cannabinoids. This step is followed by the enzymatic conversion of cannabigerolic acid into tetrahydrocannabinolic acid, cannabidiolic acid, and other cannabinoids by a family of cannabinoid oxidocyclase enzymes. Disruption of these enzymes can lead to the accumulation of cannabigerolic acid, resulting in a cannabigerol-dominant cannabinoid profile. Previous research has identified several independent mutations that, when homozygous, result in this cannabigerol-dominant cannabinoid profile. In this study, we characterized the architecture of the haplotypes surrounding four of these mutations, including a structural variant with a complete deletion of cannabidiolic acid synthase. Additionally, we compared these haplotypes to homologous regions from more than 150 publicly available genome assemblies to put them in the context of global variation at this important and structurally variable genomic region identifying 39 structurally-distinct haplogroups. We developed high-throughput molecular markers to assay for each of the mutated haplogroups. Further, we generated and characterized more than 30 populations complementing these mutated haplogroups with each other, and with fully functional haplogroups, to characterize haplogroup-associated variation in cannabinoid profiles. Together, our findings provide insights into the genetic basis of cannabinoid diversity and offer molecular tools for manipulating cannabinoid profiles in C. sativa.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.